Chile vs New Zealand: Number of isolates tested for ceftriaxone
Chile
867
in 2020
New Zealand
861
in 2020
Chile rank
6th
New Zealand rank
7th
Number of isolates tested for ceftriaxone over time
- Chile
- New Zealand
How they compare
Chile currently reports 867 against 861 in New Zealand, a difference of 6.
Across all 9 years both countries report, Chile has been ahead every year.
Chile ranks 6th and New Zealand ranks 7th of 52 countries.
Chile has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Chile | New Zealand | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 463 | 234 | 229 | Chile |
| 2010s | 1,027 | 379.86 | 647.57 | Chile |
| 2020s | 867 | 861 | 6 | Chile |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of isolates tested for ceftriaxone, Chile or New Zealand?
- Chile, at 867 against 861 in New Zealand as of 2020.
- What is the difference in number of isolates tested for ceftriaxone between Chile and New Zealand?
- 6, with Chile ahead.
- How many years of comparable data are there for Chile and New Zealand?
- 9 years are reported by both, from 2009 to 2020.
- How do Chile and New Zealand rank globally for number of isolates tested for ceftriaxone?
- Chile ranks 6th and New Zealand ranks 7th of 52 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Number of isolates tested for ceftriaxone. Statizoid refreshes it automatically from the source and publishes the full history for both places.